rs8078723

This is a upstream gene variant variant.

GWAS Catalog Trait Associations (3)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

leukocyte quantity

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele C
OR 0.07
p 8.0e-133
N 408,112
Large GWAS
European
Kong M et al. Genetic associations with C-reactive protein level and white blood cell count in the KARE study. International Journal of Immunogenetics 40(2):120-5 (2013)
Allele C
OR 0.16
p 3.0e-9
N 8,722
Large GWAS

neutrophil count

Nalls MA et al. Multiple loci are associated with white blood cell phenotypes. Plos Genetics 7(6):e1002113 (2011)
Allele T
OR 0.04
p 2.0e-31
N 19,509
Large GWAS
European
Keller MF et al. Trans-ethnic meta-analysis of white blood cell phenotypes. Human Molecular Genetics 23(25):6944-60 (2014)
Allele T
OR 0.04
p 3.0e-23
N 33,743
Meta-analysisLarge GWAS
multi-ancestry
Allele T
OR 0.04
p 8.0e-9
N 11,809
Large GWAS
Hispanic or Latin American

Research that mentions this SNP (1)

Strategies and issues in the detection of pathway enrichment in genome-wide association studies
MethodsN=28,191Mun-Gwan Hong et al.(2009)· Human Genetics

This methodological study develops ProxyGeneLD software for converting genome-wide SNP association data to pathway-enriched gene sets and validates it on multiple large GWAS datasets. The authors demonstrate successful replication of pathway enrichment for plasma HDL levels (with CETP and ABCA1 in lipid metabolism pathways) across independent samples and identify positional gene clustering as a major source of spurious enrichment in pathway analyses of GWAS data.

Traits studied:Crohn's diseasePlasma HDL cholesterolPlasma LDL cholesterolPlasma triglyceride levelsType 2 diabetes

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…